Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21742551 | 0.83 | GRM4 (0.37) | LMNAHSD17B10 | |
| SCHEMBL16940042 | 0.83 | LMNA (0.32) | LMNAHSD17B10 | |
| SCHEMBL15679087 | 0.82 | POLB (0.33) | LMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL29006952 | 0.81 | LMNA (0.31) | LMNAHSD17B10 | |
| Hydrochloric Acid SCHEMBL29007001 | 0.76 | LMNA (0.32) | LMNAHSD17B10 | |
| SCHEMBL4696007 | 0.76 | ALDH1A1 (0.44) | LMNAHSD17B10 | |
| SCHEMBL18274690 | 0.76 | ALDH1A1 (0.35) | — | |
| SCHEMBL2302371 | 0.76 | HCAR2 (0.39) | LMNAHSD17B10 | |
| SCHEMBL15658014 | 0.76 | TSHR (0.38) | HSD17B10 | |
| SCHEMBL16641610 | 0.75 | CYP4F2 (0.32) | LMNAHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11634710-B2 | Oligonucleotide compositions and methods thereof | WAVE LIFE SCIENCES LTD. (SG) | 2023-04-25 | — | — | US | disclosed |
| US-20200299692-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | WAVE LIFE SCIENCES LTD. (SG) | 2020-09-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200299692-A1 | OLIGONUCLEOTIDE COMPOSITIONS AND METHODS THEREOF | RBM17, HNRNPA2B1, HNRNPA1 | LMNA 860/4885HSD17B10 4220/4885 |
| US-11634710-B2 | Oligonucleotide compositions and methods thereof | RBM17, HNRNPA2B1, HNRNPA1 | LMNA 860/4885HSD17B10 4220/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.